Vancomycin Cerebrospinal Fluid Pharmacokinetics in Children with Cerebral Ventricular Shunt Infections-Reference-Cited by-同舟云学术

Vancomycin Cerebrospinal Fluid Pharmacokinetics in Children with Cerebral Ventricular Shunt Infections

Published:2014-10 Issue:10 Volume:33 Page:e270-e272
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Autmizguine Julie,Moran Cassie,Gonzalez Daniel,Capparelli Edmund V.,Smith P. Brian,Grant Gerald A,Benjamin Daniel K.,Cohen-Wolkowiez Michael,Watt Kevin M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference14 articles.

1. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens.;McGirt;Clin Infect Dis,2003

2. Cerebrospinal fluid shunt infections in infants and children in Mobile, Alabama.;Mancao;Acta Paediatr,1998

3. Vancomycin: a review of population pharmacokinetic analyses.;Marsot;Clin Pharmacokinet,2012

4. Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices.;Jorgenson;Pediatr Neurosurg,2007

5. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.;Klugman;Antimicrob Agents Chemother,1995

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment optimization by monitoring vancomycin concentration in the serum and cerebrospinal fluid in a child with cystoperitoneal shunt-related infection caused by methicillin-resistant Staphylococcus aureus: a case report and literature review;Child's Nervous System;2023-06-05

2. Treatment Optimization by Monitoring Vancomycin Concentration in the Serum and Cerebrospinal Fluid in a Child with Cystoperitoneal Shunt-related Infection Caused by Methicillin-resistant Staphylococcus aureus: A case report;2023-04-03

3. Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections;Frontiers in Pharmacology;2022-11-18

4. The CSF Vancomycin Concentration in Patients With Post-operative Intracranial Infection Can Be Predicted by the WBCs to Total Cells Ratio and the Serum Trough Concentration;Frontiers in Neurology;2022-05-13

5. Correlation between vancomycin penetration into cerebrospinal fluid and protein concentration in cerebrospinal fluid/serum albumin ratio;Journal of Infection and Chemotherapy;2019-02